key: cord-0696242-tyhv2x8v
authors: Neupane, Netra Prasad; Karn, Abhishek Kumar; Mukeri, Imdad Husen; Pathak, Prateek; Sharma, Praveen Kumar; Singh, Samayaditya; Qureshi, Insaf Ahmed; Jha, Tarun; Verma, Amita
title: Molecular dynamics analysis of phytochemicals from Ageratina adenophora against COVID-19 main protease (M(pro)) and human angiotensin-converting enzyme 2 (ACE2)
date: 2021-01-27
journal: Biocatal Agric Biotechnol
DOI: 10.1016/j.bcab.2021.101924
sha: 53655dde4bd299f96689ff544bb72d1496200413
doc_id: 696242
cord_uid: tyhv2x8v

The outbreak of COVID-19 created unprecedented strain in the healthcare system. Various research revealed that COVID-19 main protease (M(pro)) and human angiotensin-converting enzyme 2 (ACE2) are responsible for viral replication and entry into the human body, respectively. Blocking the activity of these enzymes gives a potential therapeutic target for the COVID-19. The objective of the study was to explore phytochemicals from Ageratina adenophora against SARS-CoV-2 through in-silico studies. In this study, 34 phytochemicals of A. adenophora were docked with M(pro) and ACE2 through AutoDock Tools-1.5.6 and their binding affinity was studied. Phytochemicals with higher affinity have been chosen for further molecular dynamics simulations to determine the stability with target protein. Molecular dynamics simulations were studied on GROMACS 5.1.4 version. Furthermore, 5-β-glucosyl-7-demethoxy-encecalin (5GDE) and 2-oxocadinan-3,6(11)-dien-12,7-olide (BODO) were found to be potential blockers with excellent binding affinity with M(pro) and ACE2 than their native inhibitors remdesivir and hydroxychloroquine respectively. The drug likeness study and pharmacokinetics of the phytoconstituents present in A. adenophora provide an excellent support for the lead drug discovery against COVID-19.

The crystal structure of a COVID-19 main protease (M pro ) and human angiotensin-converting 148 enzyme-2 (ACE2) related carboxypeptidase has been downloaded from protein data bank (PDB) 149 website (http://www.rcsb.org/pdb) (Berman et al. 2000 ) (PDB ID: 6LU7 and 1R42) and were 150 prepared by using Autodock tools-1.5.6. Kollman charges were added to each atom, non-polar 151 hydrogens were merged, atom types were determined, and the structure of the prepared receptor 152 were saved as pdbqt file. Active site selection 163 The active site of the COVID-19 M pro protein (PDB ID: 6LU7) and Human ACE2 protein (PDB 164 ID: 1R42) has been predicted from different receptor cavities available. The different active site 165 was identified from Discovery Studio 2020 (BIOVIA) client among these, site 1 of Mpro with coordinates (X= -10.711837, Y= 12.411388 and Z = 68.831286 ) and ACE2 receptor 167 with coordinates (X= 44.98, Y= 20.98 and Z= 16.80) have been chosen as the active site.

Virtual molecular docking 169 The receptor and ligand interaction through virtual molecular docking have been performed 170 through AutoDock Tools-1.5.6. All the molecules have been docked to active site 1 of COVID- The effects of the ligands on the structural dynamics of proteins were studied on GROMACS 176 5.1.4 version (Abraham et al., 2015) . Each complex and apo forms of the M pro and ACE2 proteins were considered for the study. Additionally, the protein and water topology were defined by GROMOS43A2 force field (van Gunsteren et al., 1996) and SPC/E water model 179 (Berendsen et al., 1987) , respectively. Each ligand topology was generated through the same 180 force field using the PRODRG server (http://prodrg2.dyndns.org/submit.html). The charge of 181 each simulating system was neutralized by an appropriate number of sodium ions (Na + ).

Subsequently, the energy of the simulating systems was minimized by the steepest descent 183 algorithm in 50000 steps. The two-phase equilibration of 100ps was carried out by NVT (at 184 constant 300K) and NPT (at constant 1 bar) ensemble equilibrations for each system.

Consequently, MD simulation of 50ns was carried out for each system and the data was used for 186 the enumeration of RMSD, RMSF and Rg. Furthermore, the binding energy was enumerated by 

These interactions are compared with native inhibitor N3 and it was found that 90.90% amino 225 acid showed similarity with that of a co-crystal ligand, which was found acceptable. Thus, the 226 protein was further utilized for docking 34 different compounds reported in A. adenophora and 227 docking score is displayed in (affinity Kcal/mol) 1 7-hydroxy-dehydrotremetone -6.3 -5.7 2 7,10,11-trihydroxy dehydrotremetone -6.6 -6.2 3 10-oxo-7-hydroxy-nordehydrotremetone -6.2 -5.7

(4S,4aR,6R)-1-acetyl-6-(acetyloxy)-4,4a,5,6tetrahydro-4,7-dimethylnaphthalen-2(3H)-one -6.6 -5.7

J o u r n a l P r e -p r o o f 2-deoxo-2-(acetyloxy)-9oxoageraphorone(DAOA) -6.2 -6.0 9 9-oxoagerophorone(OA) -5.9 -5.3 10 9-oxo-10,11-dehydro-agerophorone(ODA) -6.0 -5.9 11 9β-hydroxy-ageraphorone -5.8 -5.4

12 Muurol-4-en-7-ol -5.7 -5.5 13 8-beta-hydroxy-9,12-dehydroverbocciolenten -5.5 -5.2 14 2 β-acetoxy-(7α, 9β H)-3.6(11)-cadinadien-12(7)-olide -6.9 -6.4 22 5,6-dihydroxy candinan-3-ene-2,7-dione -6.5 -5.9

23 2-acetyl-candinan-3,6-diene-7-one -6.1 -6.1 24 Candinan-3-ene-2,7-dione -5.8 -5.3 25 Candinan-3,6-diene-2,7-dione -6.2 -5.6 26 1,6-dihydroxy-1-isopropyl-4,7-dimethyl-3,4dihydronaphthalen-2(1H)-one The human ACE2 enzyme is composed of two domains; the first is zinc metallopeptidase Table 3 .

Top 5 high scoring compounds has been taken into consideration for further detailed analysis as 265 reflected in the Table 3 . BODO has shown the best binding affinity towards the human ACE2 266 receptor with a binding energy of -8.7 Kcal/mol. This binding energy is higher than best fit 267 inhibitor (Hydroxychloroquine) binding affinity, which is -6.3 Kcal/mol. The best fit inhibitor This will lead to cost effective drug can be develop. The backbone atom fluctuation of the ACE2 residues was analyzed by the RMSF data, which 326 showed similar levels of fluctuation in apo and complex forms with an average RMSF of 0.15 327 and 0.14 nm, respectively. The MD analysis showed that the ACE2 complex structure retains stability during the simulation. The RMSF graph is displayed in Figure 7 . Our aim of the study was to investigate efficiency of the phytocompounds against coronavirus.

Therefore, the phytochemicals of A. adenophora are in-silico tested against M pro and ACE2 385 receptor. Furthermore, the docking calculation confirmed that the phytocompound 5GDE consist 386 significant identical interaction with selected protein as referenced compounds. However, the 387 binding energy was measure slightly above than standard drug remdisivir and 388 hydroxychloroquine.

The MD analysis of M pro complex structure found to retain similar 389 compactness like its apo structure, but with increased structural stability and low residues 390 fluctuation in comparison to the apo form during the simulation. Whereas, phytochemical 391 BODO has shown high binding affinity (score), almost stable interaction with ACE2 receptor, 392 retain similar compactness, and residues motion like its apo structure, but with increased 393 structural stability during the simulation.

Our study showed natural compounds from A. adenophora have either similar or greater binding 395 affinity than that of natural inhibitor remdesivir and hydroxychloroquine. 

Penaeus monodon prawns: an invertebrate virus with ORF1a and ORF1b genes related to

The authors are very grateful to the Department of Biotechnology and Bioinformatics, School of 402 Life Sciences, University of Hyderabad, Hyderabad, Telangana, India. Prateek Pathak